A detailed history of Intermede Investment Partners LTD transactions in Danaher Corp stock. As of the latest transaction made, Intermede Investment Partners LTD holds 621,752 shares of DHR stock, worth $142 Million. This represents 3.61% of its overall portfolio holdings.

Number of Shares
621,752
Previous 633,713 1.89%
Holding current value
$142 Million
Previous $158 Million 9.17%
% of portfolio
3.61%
Previous 3.35%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$239.25 - $280.76 $2.86 Million - $3.36 Million
-11,961 Reduced 1.89%
621,752 $173 Million
Q2 2024

Jul 17, 2024

SELL
$235.51 - $267.98 $44.2 Million - $50.2 Million
-187,492 Reduced 22.83%
633,713 $158 Million
Q1 2024

May 10, 2024

SELL
$224.58 - $256.19 $12.1 Million - $13.8 Million
-53,862 Reduced 6.16%
821,205 $205 Million
Q4 2023

Feb 12, 2024

BUY
$185.1 - $233.13 $11.5 Million - $14.5 Million
62,115 Added 7.64%
875,067 $202 Million
Q3 2023

Nov 08, 2023

SELL
$233.08 - $265.59 $7.52 Million - $8.56 Million
-32,245 Reduced 3.82%
812,952 $202 Million
Q2 2023

Aug 09, 2023

SELL
$224.99 - $256.14 $306,886 - $349,374
-1,364 Reduced 0.16%
845,197 $203 Million
Q1 2023

May 15, 2023

BUY
$239.75 - $277.0 $854,469 - $987,228
3,564 Added 0.42%
846,561 $213 Million
Q4 2022

Feb 09, 2023

SELL
$241.42 - $282.29 $640,728 - $749,197
-2,654 Reduced 0.31%
842,997 $224 Million
Q3 2022

Oct 24, 2022

SELL
$247.06 - $1507.4 $12.2 Million - $74.2 Million
-49,199 Reduced 5.5%
845,651 $218 Million
Q2 2022

Aug 03, 2022

BUY
$237.11 - $299.66 $6.12 Million - $7.74 Million
25,824 Added 2.97%
894,850 $227 Million
Q1 2022

Apr 28, 2022

BUY
$257.27 - $315.76 $15.2 Million - $18.7 Million
59,211 Added 7.31%
869,026 $255 Million
Q4 2021

Jan 14, 2022

SELL
$292.08 - $329.01 $31.8 Million - $35.9 Million
-109,044 Reduced 11.87%
809,815 $266 Million
Q3 2021

Oct 27, 2021

SELL
$272.21 - $332.43 $2.51 Million - $3.07 Million
-9,228 Reduced 0.99%
918,859 $280 Million
Q2 2021

Jul 30, 2021

BUY
$225.08 - $271.69 $9.92 Million - $12 Million
44,065 Added 4.98%
928,087 $249 Million
Q1 2021

May 07, 2021

BUY
$212.38 - $245.9 $38.6 Million - $44.7 Million
181,852 Added 25.9%
884,022 $199 Million
Q4 2020

Feb 05, 2021

BUY
$212.5 - $245.46 $29.2 Million - $33.7 Million
137,214 Added 24.29%
702,170 $156 Million
Q3 2020

Oct 29, 2020

BUY
$177.16 - $215.33 $2.59 Million - $3.15 Million
14,645 Added 2.66%
564,956 $122 Million
Q2 2020

Aug 06, 2020

SELL
$128.7 - $176.83 $2.4 Million - $3.29 Million
-18,622 Reduced 3.27%
550,311 $97.3 Million
Q1 2020

May 11, 2020

SELL
$121.39 - $169.05 $1.17 Million - $1.63 Million
-9,618 Reduced 1.66%
568,933 $78.7 Million
Q4 2019

Feb 10, 2020

BUY
$133.47 - $153.48 $1.26 Million - $1.44 Million
9,407 Added 1.65%
578,551 $88.8 Million
Q3 2019

Nov 01, 2019

SELL
$135.4 - $146.47 $930,062 - $1.01 Million
-6,869 Reduced 1.19%
569,144 $82.2 Million
Q2 2019

Jul 30, 2019

SELL
$124.88 - $143.73 $1.05 Million - $1.21 Million
-8,400 Reduced 1.44%
576,013 $82.3 Million
Q1 2019

May 01, 2019

BUY
$97.62 - $132.29 $6.88 Million - $9.33 Million
70,513 Added 13.72%
584,413 $77.2 Million
Q4 2018

Feb 14, 2019

BUY
$94.85 - $109.54 $2.45 Million - $2.83 Million
25,830 Added 5.29%
513,900 $53 Million
Q3 2018

Oct 29, 2018

BUY
$98.13 - $108.9 $1.93 Million - $2.14 Million
19,625 Added 4.19%
488,070 $53 Million
Q2 2018

Aug 08, 2018

BUY
$96.1 - $103.24 $2.72 Million - $2.92 Million
28,255 Added 6.42%
468,445 $46.2 Million
Q1 2018

May 01, 2018

SELL
$92.16 - $103.8 $2.35 Million - $2.64 Million
-25,475 Reduced 5.47%
440,190 $43.1 Million
Q4 2017

Jan 19, 2018

BUY
$85.26 - $94.62 $1.86 Million - $2.06 Million
21,809 Added 4.91%
465,665 $43.2 Million
Q3 2017

Oct 24, 2017

BUY
$79.29 - $88.45 $35.2 Million - $39.3 Million
443,856
443,856 $38.1 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $166B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Intermede Investment Partners LTD Portfolio

Follow Intermede Investment Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intermede Investment Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Intermede Investment Partners LTD with notifications on news.